标题：Corrigendum: Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases
摘要：Scientific Reports 5 : Article number: 11827 10.1038/srep11827 ; published online: 14 July 2015 ; updated: 18 September 2015 In this Article, Manos Perros and Ruben Tommasi are incorrectly listed as being affiliated with ‘Shire Pharmaceuticals, 300 Shire Way, Lexington, MA 02421.’ The correct affiliation is listed below: Entasis Therapeutics, 35 Gatehouse Drive Suite E0, Waltham, MA 02415 USA In addition, Renu Singh is incorrectly listed as being affiliated with ‘Department of Chemistry, Drug Discovery and Development Center, University of Cape Town, Rondebosch 7701, South Africa.
